New enzyme for reductive cancer chemotherapy, YieF, and its improvement by directed evolution
Open Access
- 1 January 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- Vol. 5 (1), 97-103
- https://doi.org/10.1158/1535-7163.mct-05-0365
Abstract
Reductive prodrugs, mitomycin C and 5-aziridinyl-2,4-dinitrobenzamide (CB 1954), are nontoxic in their native form but become highly toxic upon reduction. Their effectiveness in cancer chemotherapy can be enhanced by delivering to tumors enzymes with improved prodrug reduction kinetics. We report the discovery of a new prodrug-reducing enzyme, YieF, from Escherichia coli, and the improvement of its kinetics for reducing mitomycin C and CB 1954. A YieF-derived enzyme, Y6, killed HeLa spinner cells with ≥5-fold efficiency than the wild-type enzymes, YieF and NfsA, at a variety of drug and enzyme concentrations and incubation times. With adhered HeLa cells and Salmonella typhimurium SL 7838 bacteria as enzyme delivery vehicle, at least an order of magnitude less of Y6-producing bacteria were required to kill >90% of tumor cells compared with bacteria expressing the wild-type enzymes, which at a comparable level killed Salmonella strain SL 7838, which specifically targets tumors, may be used to deliver the prodrug-activating enzymes to tumors. [Mol Cancer Ther 2006;5(1):97–103]Keywords
This publication has 18 references indexed in Scilit:
- Temporal targeting of tumour cells and neovasculature with a nanoscale delivery systemNature, 2005
- Alanine-Scanning Mutagenesis Reveals a Cytosine Deaminase Mutant with Altered Substrate PreferenceBiochemistry, 2004
- Mechanism of chromate reduction by the Escherichia coli protein, NfsA, and the role of different chromate reductases in minimizing oxidative stress during chromate reductionEnvironmental Microbiology, 2004
- Aziridinyldinitrobenzamides: Synthesis and Structure−Activity Relationships for Activation by E. coli NitroreductaseJournal of Medicinal Chemistry, 2004
- Chromate-Reducing Properties of Soluble Flavoproteins from Pseudomonas putida and Escherichia coliApplied and Environmental Microbiology, 2004
- Current Progress in Suicide Gene Therapy for CancerWorld Journal of Surgery, 2002
- The structure of Escherichia coli nitroreductase complexed with nicotinic acid: three crystal forms at 1.7 Å, 1.8 Å and 2.4 Å resolutionJournal of Molecular Biology, 2001
- The Complete Genome Sequence of Escherichia coli K-12Science, 1997
- Tuning the activity of an enzyme for unusual environments: sequential random mutagenesis of subtilisin E for catalysis in dimethylformamide.Proceedings of the National Academy of Sciences, 1993
- Improved site-directed mutagenesis method using PCRNucleic Acids Research, 1991